Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Myriad Genetics Reports Nov. 2 Network Breach

Myriad Genetics, Inc. filed a Form 8-K on November 5, 2026, disclosing that it detected unauthorized access within its information technology network environment on November 2, 2026.

Aakashdeep | 05 November 2026

MetaVia Reports Positive DA-1726 Phase 1 Interim Data

MetaVia Inc. filed a Form 8-K with the U.S. Securities and Exchange Commission on November 5, 2026, disclosing positive interim clinical trial data and an updated corporate presentation.

Manish Choudhary | 05 November 2026

Dropbox to Acquire Tigris Data for $350 Million

Dropbox, Inc. filed a Form 8-K with the SEC on November 5, 2026, disclosing a definitive agreement to acquire Tigris Data Inc. for approximately $350 million in cash, signed on November 3, 2026, and announcing the launch of a new offering called DBX Agent …

Anjali Anand | 05 November 2026

Construction Partners Discloses FY2026 Prelim Results and Acquisition

Construction Partners, Inc. filed a Form 8-K on November 5, 2026, disclosing preliminary financial results for the fiscal year ended September 30, 2026, a preliminary outlook for the fiscal year ending September 30, 2027, and the completion of an acquisition transaction announced on November …

Manish Choudhary | 05 November 2026

Tractor Supply Declares $0.24 Cash Dividend, Payable Dec. 8

Tractor Supply Company filed a Form 8-K with the SEC on November 5, 2026, announcing the declaration of a cash dividend of $0.24 per share of common stock, payable December 8, 2026, to stockholders of record as of the close of business on November …

Vinay Lochav | 05 November 2026

Chatham Lodging Trust Files Q3 2026 Results 8-K

Chatham Lodging Trust filed a Form 8-K with the SEC on November 5, 2026, announcing the release of its results of operations for the three months ended September 30, 2026.

Nitish Kishor | 05 November 2026

AIM ImmunoTech Files Ampligen Opportunity Presentation Nov 5

AIM ImmunoTech Inc. filed a Form 8-K with the SEC on November 5, 2026, furnishing a corporate presentation titled "The Ampligen Opportunity" and an accompanying press release under Regulation FD.

Vinay Lochav | 05 November 2026

First Business Financial Services Posts Investor Presentation Nov 2026

First Business Financial Services, Inc. filed a Form 8-K on November 5, 2026, disclosing that it had posted an investor presentation covering recent operating performance, financial condition, and business strategy for use in executive interactions with shareholders and analysts.

Anjali Anand | 05 November 2026

Kairos Pharma Wins 2026 Biotech Breakthrough Award for ENV-105

Kairos Pharma, Ltd. filed a Form 8-K on November 5, 2026, disclosing that the company has been named a winner of the 2026 Biotech Breakthrough Awards in the category of Cancer Immunology Solution of the Year for its work with ENV-105 (carotuximab).

Shwetambri Chauhan | 05 November 2026

Digital Turbine Names Daniel Lentz CFO With $450K Salary

Digital Turbine, Inc. filed a Form 8-K on November 5, 2026, disclosing the appointment of Daniel Lentz as Chief Financial Officer, effective November 2, 2026, along with the terms of his employment agreement and equity awards.

Vinay Lochav | 05 November 2026
Support

Hi! How can we help you today?

Loading…